
Seerlinq is taking non-invasive diagnostics, disease monitoring and treatment optimization to a new level by utilising state-of-the-art machine learning PPG analysis, and our medical expertise. We are reinventing the way of looking at the PPG curve by using artificial intelligence to analyse all measured parameters comprehensively. Furthermore, we are using our worldwide network of physicians and clinical researchers to collect medically labelled data. Our mission is to personalise treatment and diagnostics of cardiovascular diseases by analysing PPG signal with machine learning.
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.